Detalhe da pesquisa
1.
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
Int J Cancer
; 154(5): 863-872, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840339
2.
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
J Antimicrob Chemother
; 78(8): 1813-1826, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311136
3.
[Chemotherapy-induced nausea and vomiting]. / Chemotherapieinduzierte Nausea und Emesis.
HNO
; 71(7): 473-484, 2023 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-37268826
4.
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Lancet
; 397(10273): 499-509, 2021 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33549194
5.
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
Int J Cancer
; 148(8): 1919-1927, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113215
6.
Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Ann Hematol
; 100(2): 321-336, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079221
7.
Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Ann Hematol
; 100(1): 239-259, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997191
8.
Real-world evidence of NEPA, netupitant-palonosetron, in chemotherapy-induced nausea and vomiting prevention: effects on quality of life.
Future Oncol
; 16(14): 939-953, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298187
9.
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Mycoses
; 63(7): 653-682, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236989
10.
Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer.
BMC Cancer
; 18(1): 1124, 2018 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445951
11.
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).
Mycoses
; 61(11): 796-813, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30098069
12.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet
; 387(10020): 760-9, 2016 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26684607
13.
Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma.
Int J Colorectal Dis
; 32(8): 1179-1190, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424871
14.
NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron.
Support Care Cancer
; 25(4): 1127-1135, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27885469
15.
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.
Br J Cancer
; 115(10): 1215-1222, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27764839
16.
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach.
Ann Hematol
; 94(4): 547-56, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25697592
17.
Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting.
Future Oncol
; 11(4): 565-77, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25360998
18.
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC).
Support Care Cancer
; 23(10): 2917-23, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724407
19.
Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
Ann Hematol
; 93(9): 1449-56, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24951122
20.
Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212).
Clin Cancer Res
; 30(7): 1256-1263, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289994